Pegylated interferon alpha 2a is an effective and well‐tolerated treatment option for lymphocyte‐variant hypereosinophilic syndrome-Reference-Cited by-同舟云学术

Pegylated interferon alpha 2a is an effective and well‐tolerated treatment option for lymphocyte‐variant hypereosinophilic syndrome

Author:

Choi Charles¹,Moller Daniel²,Tan Julia²,Dou Carol¹,Peterson Erica A.³,Medvedev Nadia⁴,Dutz Jan P⁵,Carruthers Mollie N.⁶,Chen Luke Y. C.³^ORCID

Affiliation:

1. Faculty of Medicine University of British Columbia Vancouver BC Canada

2. Department of Medicine University of British Columbia Vancouver BC Canada

3. Division of Hematology University of British Columbia Vancouver BC Canada

4. Department of Pathology and Laboratory Medicine University of British Columbia Vancouver BC Canada

5. Department of Dermatology and Skin Science University of British Columbia Vancouver BC Canada

6. Division of Rheumatology University of British Columbia Vancouver BC Canada

Publisher

Wiley

Subject

Hematology

Link

Reference10 articles.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献